SSREF (Swiss Re AG) ROC (Joel Greenblatt) %: % (As of Dec. 2025)


SSREF Swiss Re AG SSREF
67 GF Score
Price $158.02
GF Value $134.07
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Swiss Re AG ROC (Joel Greenblatt) %?

Swiss Re AG SSREF +2.90% 67 ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus rates SSREF with a GF Score™ of 67/100 and a GF Value™ of $134.07 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 63 Insurance companies, Swiss Re AG ranks worse than 1587300% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

SSREF
67GF Score
Swiss Re AG SSREF
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Swiss Re AG (SSREF) has a ROC (Joel Greenblatt) % of % as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Swiss Re AG and its competitors. According to the industry distribution chart, Swiss Re AG ranks #999999 out of 63 companies in the Insurance industry.
Is Swiss Re AG's ROC (Joel Greenblatt) % too high?
Swiss Re AG's current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Swiss Re AG ranks #999999 out of 63 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Swiss Re AG has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Swiss Re AG's ROC (Joel Greenblatt) % compare to RGA and EG?
According to the Insurance industry distribution chart, Swiss Re AG ranks #999999 out of 63 companies for ROC (Joel Greenblatt) %. This places Swiss Re AG in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 79.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for an Insurance company?
The median ROC (Joel Greenblatt) % among Insurance companies is 79.14, based on 63 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Swiss Re AG and its competitors. For the Insurance industry, the median ROC (Joel Greenblatt) % is 79.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Swiss Re AG's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Swiss Re AG stock overvalued right now?
Based on GuruFocus' analysis, Swiss Re AG (SSREF) is currently considered Modestly Overvalued. The stock's GF Value™ is $134.07, compared to a current price of $158.02 — trading 17.9% above its estimated fair value. The current ROC (Joel Greenblatt) % is %. Swiss Re AG's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Swiss Re AG (SSREF), the current ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Swiss Re AG (SSREF) Overvalued in 2026?

Based on GuruFocus' analysis, Swiss Re AG stock appears to be overvalued. The current stock price of $158.02 is trading 17.9% above its estimated GF Value™ of $134.07. GuruFocus considers Swiss Re AG to be Modestly Overvalued.

Key valuation signals for SSREF:

  • ROC (Joel Greenblatt) %: %
  • GF Value™: $134.07 vs. price of $158.02 (17.9% above fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the SSREF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Swiss Re AG Business Description

Address Mythenquai 50/60, Zurich, CHE, 8022
Swiss Re is a reinsurer that has three core divisions: P&C reinsurance, life and health reinsurance, and corporate solutions. Swiss Re was founded in 1863 when the general manager of Helvetia sought to stem the flow of reinsurance premiums outside Switzerland. Moritz Grossmann argued he could cut the premiums paid to foreign firms, still make a profit, and pay mid-single-digit dividends. Swiss Re is now the second-largest reinsurer in the world by market capitalization, with 80 offices around the world and approximately 15,000 employees. While the business did lose its way in the early part of the millennium, led by an investment banker who heavily invested in securitizations, Swiss Re has recently focused on establishing quality within its three core divisions.
67GF Score

Get the complete analysis for SSREF

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$158.02
Price
$134.07
GF Value